Omeros | OMER - Loan Capital


Omeros reported $403.72M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Adma Biologics USD 193.58M 124.25M Mar/2026
Alnylam Pharmaceuticals USD 2.48B 931K Mar/2026
BioMarin Pharmaceutical USD 1.43B 833.11M Mar/2026
Cytokinetics USD 247.21M 868.77M Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
Heron Therapeutics USD 140.64M 975K Dec/2025
Immunic USD 0 0 Jun/2024
Insmed USD 542.22M 1.25M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
MacroGenics USD 68.71M 1.29M Mar/2026
Omeros USD 403.72M 27.2M Jun/2024
Pacira USD 367.66M 4.53M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Rockwell Medical USD 8.65M 89K Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 838.16M 9.19M Mar/2026
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025
Xoma USD 94.38M 7.82M Sep/2025